Y1 | Y2 | Y3 | Y4 | Y5 | Source | |
---|---|---|---|---|---|---|
Base case | ||||||
Transition probabilities | ||||||
Usual care CP to CP | 0.494 | 0.368 | 0.388 | 0.400 | 0.406 | STAR trial (Y1), COASt (Y2-Y5) |
Usual care CP to NCP | 0.506 | 0.632 | 0.612 | 0.600 | 0.594 | |
Usual care NCP to CP | 0.000 | 0.050 | 0.042 | 0.031 | 0.037 | |
Usual care NCP to NCP | 0.000 | 0.950 | 0.958 | 0.969 | 0.963 | |
STAR care pathway CP to CP | 0.355 | 0.368 | 0.388 | 0.400 | 0.406 | |
STAR care pathway CP to NCP | 0.645 | 0.632 | 0.612 | 0.600 | 0.594 | |
STAR care pathway NCP to CP | 0.000 | 0.050 | 0.042 | 0.031 | 0.037 | |
STAR care pathway NCP to NCP | 0.000 | 0.950 | 0.958 | 0.969 | 0.963 | |
Quality Adjusted Life Years | ||||||
Usual care CP | 0.465 | 0.556 | 0.607 | 0.642 | 0.698 | STAR trial (level), COASt (progression) |
Usual care NCP | 0.539 | 0.730 | 0.727 | 0.716 | 0.702 | |
STAR care pathway CP | 0.484 | 0.572 | 0.621 | 0.654 | 0.708 | |
STAR care pathway NCP | 0.560 | 0.742 | 0.739 | 0.728 | 0.714 | |
Cost (£) | ||||||
STAR care pathway | 191 | 0 | 0 | 0 | 0 | STAR trial |
Prescriptions CP | 100 | 88 | 91 | 91 | 91 | STAR trial (level), CPRD (progression) |
Prescriptions NCP | 22 | 18 | 17 | 17 | 18 | |
Medical consultations CP | 166 | 143 | 137 | 137 | 125 | STAR trial (level), CPRD (progression) |
Medical consultations NCP | 62 | 51 | 48 | 46 | 48 | |
Usual care hospital admissions CP | 2,972 | 898 | 464 | 65 | 24 | STAR trial (level), COASt (progression) |
Usual care hospital admissions NCP | 1,057 | 386 | 331 | 82 | 249 | |
STAR care pathway hospital admissions CP | 1,265 | 898 | 464 | 65 | 24 | STAR trial (level), COASt (progression) |
STAR care pathway hospital admissions NCP | 1,302 | 386 | 331 | 82 | 249 | |
Sensitivity analysis - scenario analysis | ||||||
Quality Adjusted Life Years– Scenario 1 | ||||||
CP | 0.477 | 0.566 | 0.616 | 0.650 | 0.704 | STAR trial (level), COASt (progression) |
NCP | 0.555 | 0.739 | 0.736 | 0.725 | 0.711 | |
Transition probabilities– Scenario 2 | ||||||
Usual care CP to CP | 0.500 | 0.368 | 0.388 | 0.400 | 0.406 | STAR trial (Y1), COASt (Y2-Y5) |
Usual care CP to NCP | 0.500 | 0.632 | 0.612 | 0.600 | 0.594 | |
Usual care NCP to CP | 0.000 | 0.050 | 0.042 | 0.031 | 0.037 | |
Usual care NCP to NCP | 1.000 | 0.950 | 0.958 | 0.969 | 0.963 | |
STAR care pathway CP to CP | 0.357 | 0.368 | 0.388 | 0.400 | 0.406 | |
STAR care pathway CP to NCP | 0.643 | 0.632 | 0.612 | 0.600 | 0.594 | |
STAR care pathway NCP to CP | 0.222 | 0.050 | 0.042 | 0.031 | 0.037 | |
STAR care pathway NCP to NCP | 0.778 | 0.950 | 0.958 | 0.969 | 0.963 | |
Cost (£)– Scenario 3 | ||||||
Hospital admissions CP | 1,935 | 898 | 464 | 65 | 24 | STAR trial (level), COASt (progression) |
Hospital admissions NCP | 1,237 | 386 | 331 | 82 | 249 |